Stay well informed

Investor News

We would like to inform you about the current business development of HAEMATO AG as well as about our investor relations activities.

Ad hoc of HAEMATO AG:HAEMATO PHARM GmbH as a subsidiary of HAEMATO AG (symbol: HAEK) received a special approval in accordance with § 11 Para. 1 MPG from the Federal Institute for Drugs and Medical Devices ( BfArM) for the antigen rapid test for self-testing by laypersons on 23 March 2021. The exact name of […]

Patrick Brenske, member of the Executive Board of HAEMATO AG since November 30, 2020 and Head of Purchasing and Sales of the HAEMATO Group for approximately eight years until 2015, will lead HAEMATO AG as sole member of the Executive Board in the future.

Berlin, 15.12.2020 – M1 Kliniken AG and HAEMATO AG today signed a contract for the acqui-sition of all shares in M1 Aesthetics GmbH by HAEMATO AG. M1 Kliniken AG will contribute M1 Aesthetics GmbH to HAEMATO AG within the scope of a capital increase through contri-bution in kind. For this purpose, the Management Board of HAEMATO AG decided today …

[et_pb_section fb_built=“1″ _builder_version=“3.22″][et_pb_row _builder_version=“3.25″ background_size=“initial“ background_position=“top_left“ background_repeat=“repeat“][et_pb_column type=“4_4″ _builder_version=“3.25″ custom_padding=“|||“ custom_padding__hover=“|||“][et_pb_text _builder_version=“4.4.8″] HAEMATO AG: Expansion of the board of …

[et_pb_section fb_built=“1″ _builder_version=“3.22″][et_pb_row _builder_version=“3.25″ background_size=“initial“ background_position=“top_left“ background_repeat=“repeat“][et_pb_column type=“4_4″ _builder_version=“3.25″ custom_padding=“|||“ custom_padding__hover=“|||“][et_pb_text _builder_version=“4.6.0″ hover_enabled=“0″ sticky_enabled=“0″] …

[et_pb_section fb_built=“1″ _builder_version=“3.22″][et_pb_row _builder_version=“3.25″ background_size=“initial“ background_position=“top_left“ background_repeat=“repeat“][et_pb_column type=“4_4″ _builder_version=“3.25″ custom_padding=“|||“ custom_padding__hover=“|||“][et_pb_text _builder_version=“4.5.1″ hover_enabled=“0″] In the first half of …

For investors

Do you have any further questions about the group? Our investor relations team is happy to help you..

Contact us